AAV-dependent targeting of myostatin function: follistatin strikes back at muscular dystrophy. (Q45878156)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528431%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

AAV-dependent targeting of myostatin function: follistatin strikes back at muscular dystrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528431%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528431%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Carlo Gaetano

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528431%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

M C Capogrossi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528431%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

5 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528431%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528431%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528431%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528431%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

1075-1076

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18528431%20AND%20SRC:MED&resulttype=core&format=json

Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.95

Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.95

Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.95

Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.95

Functional improvement of dystrophic muscle by myostatin blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.95

Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.95

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.95

Immunity to adeno-associated virus vectors in animals and humans: a continued challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.95

Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.95

inferred from DOI database lookup

7 January 2021

based on heuristic

Loss of myostatin attenuates severity of muscular dystrophy in mdx mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.95